Daily Oral Grepafloxacin vs. Twice Daily Oral
Doxycycline in the Treatment of Chlamydia trachomatis
Endocervical Infection

W. M. McCormack; D. H. Martin; E.  W. Hook III; R. B. Jones

doi:10.1155/S1064744998000210

Infectious Diseases in Obstetrics and Gynecology (Jan 1998)

Daily Oral Grepafloxacin vs. Twice Daily Oral Doxycycline in the Treatment of Chlamydia trachomatis Endocervical Infection

W. M. McCormack,
D. H. Martin,
E. W. Hook III,
R. B. Jones

Affiliations

W. M. McCormack: SUNY Health Science Center at Brooklyn, Box 56, 450 Clarkson Avenue, Brooklyn, NY 11203, USA
D. H. Martin: Louisiana State University and the Delgado Clinic, New Orleans, LA, USA
E. W. Hook III: University of Alabama at Birmingham, Birmingham, AL, USA
R. B. Jones: Indiana University Scaool of Medicine, Indianapolis, IN, USA

DOI: https://doi.org/10.1155/S1064744998000210
Journal volume & issue: Vol. 6, no. 3
pp. 109 – 115

Abstract

Read online

Objective: To compare the efficacy and safety of a 7-day course of treatment with oral grepafloxacin, 400 mg once daily, and oral doxycycline, 100 mg twice daily, in patients with chlamydial cervicitis.

Published in Infectious Diseases in Obstetrics and Gynecology

ISSN: 1064-7449 (Print); 1098-0997 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Gynecology and obstetrics; Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://onlinelibrary.wiley.com/journal/7281

About the journal